Phillips 66
4 nominees · 2 ballot items.
Election of four Class II directors; advisory (non-binding) approval of named executive officer compensation (Say-on-Pay); and ratification of Ernst & Young LLP as independent auditor.
Follow how the vote landed and what changed on Phillips 66’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot2
- 1
Election of four Class II Directors to hold office until the 2029 Annual Meeting
ManagementBoard: FORElection of four Class II director nominees (Gregory J. Hayes, Charles M. Holley, Denise R. Singleton and Howard I. Ungerleider) to serve three-year terms expiring in 2029.
- 2
Advisory approval of executive compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.
More detail
The proposal requests an advisory, non-binding approval of the Company's executive compensation as disclosed in the Proxy Statement, allowing shareholders to express their view on pay practices (
Nominees on the ballot4
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 26,107,984 | $4.8B |
| 2 | STATE STREET CORP | 6.4% | 25,772,853 | $4.7B |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.5% | 22,100,692 | $4.0B |
| 4 | Elliott Investment Management L.P.Activist | 4.8% | 19,251,000 | $3.5B |
| 5 | BlackRock, Inc. | 3.5% | 14,000,121 | $2.6B |
| 6 | WELLS FARGO COMPANY/MN | 2.4% | 9,657,990 | $1.8B |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 9,365,711 | $1.7B |
| 8 | HARRIS ASSOCIATES L P | 2.2% | 8,846,589 | $1.6B |
| 9 | BlackRock, Inc. | 2.1% | 8,414,490 | $1.5B |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.0% | 4,193,176 | $764M |
Other Energy sector meetings6
Upcoming shareholder meetings at Phillips 66’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Phillips 66 2026 annual meeting?
- Phillips 66 (PSX) holds its 2026 annual shareholder meeting on Wednesday, May 13, 2026.
- What is the record date for the Phillips 66 2026 meeting?
- The record date for the Phillips 66 2026 meeting is Friday, March 20, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Phillips 66's 2026 meeting?
- The board is presenting 4 director nominees at the Phillips 66 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Phillips 66 2026 meeting?
- Shareholders will vote on 2 proposals at the Phillips 66 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.